WHO suspends hydroxychloroquine trial over safety concerns
WHO Director-General Tedros Adhanom Ghebreyesus: This concern relates to the use of hydroxychloroquine and chloraquine in Covid-19. I wish to reiterate that these drugs are accepted as generally safe for use in patients with autoimmune diseases or malaria